All In Biotech

Free tool

FAERS Monitor: Polivy

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761121 or its brand name (Polivy, Polatuzumab Vedotin-Piiq). Reports on generic versions are filed under their own applications.

Reports

10,202

Serious

9,659

95% of reports

Hospitalization

2,696

Death reported

2,154

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • disease progression2,064
  • off label use1,398
  • death801
  • neutropenia642
  • anaemia577
  • covid-19549
  • febrile neutropenia549
  • cytokine release syndrome542
  • pyrexia531
  • drug ineffective503
  • platelet count decreased434
  • diffuse large b-cell lymphoma428
  • pneumonia422
  • neutrophil count decreased421
  • blood lactate dehydrogenase increased419

Reports by year received

View as table
YearReports
20132
20142
20158
201635
201721
201832
2019253
2020467
2021719
20221,665
20232,266
20241,733
20251,550
20261,449

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,957 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
diffuse large b-cell lymphomaSignal428121.2110.148,089
cytokine release syndromeSignal54257.252.729,106
blood lactate dehydrogenase increasedSignal41955.950.921,975
disease progressionSignal2,06436.635.270,552
neutrophil count decreasedSignal42121.519.68,143
febrile neutropeniaSignal54917.215.88,316
neutropeniaSignal6429.89.15,058
platelet count decreasedSignal4348.47.72,835
covid-19Signal5496.56.02,546
anaemiaSignal5776.35.82,557
off label useSignal1,3983.33.12,326
pyrexiaSignal5313.22.9797
pneumoniaSignal4222.72.4453
death8011.91.8365
drug ineffective5030.80.731

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.